Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GMAB | Copenhagen | DKK | Real-time | |
GMABc | BATS Europe | DKK | Delayed | |
GMAB | NASDAQ | USD | Real-time | |
0MGB | London | DKK | Real-time | |
GMAB | Vienna | EUR | Real-time |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Evening Star | 1W | 3 | Mar 17, 2024 | ||
Bullish Engulfing | 15 | 6 | Apr 15, 2024 15:15 | ||
Tri-Star Bearish | 30 | 9 | Apr 15, 2024 13:00 | ||
Homing Pigeon | 1W | 10 | Jan 28, 2024 | ||
Tri-Star Bearish | 15 | 11 | Apr 15, 2024 13:15 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Copenhagen | 1,994.5 | 0.0 | 0.0 | 93,478 | -0.62% | DKK | |||
BATS Europe | 1,994.00 | 1,974.00 | 2,014.00 | 105 | -1.63% | DKK | |||
NASDAQ | 28.33 | 28.00 | 28.74 | 242,491 | -0.70% | USD | |||
London | 1,996.50 | 1,935.50 | 2,034.00 | 2,662 | -0.95% | DKK | |||
Vienna | 266.00 | 262.80 | 266.00 | 0 | +0.00% | EUR |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IAG | 169.80 | 187.90 | 163.55 | +9.10 | +5.66% | 35.30M | 18/04 | ||
Rolls-Royce Holdings | 402.50 | 406.71 | 398.30 | +1.10 | +0.27% | 34.65M | 18/04 | ||
EasyJet | 530.00 | 547.00 | 526.40 | +11.80 | +2.28% | 15.43M | 18/04 | ||
Lloyds Banking | 51.00 | 51.30 | 50.62 | +0.58 | +1.15% | 95.48M | 18/04 | ||
BP | 512.40 | 515.10 | 508.20 | -4.40 | -0.85% | 36.63M | 18/04 | ||
Ocado | 350.00 | 350.50 | 3.48 | +1.80 | +0.52% | 3.54M | 18/04 | ||
Centamin | 128.10 | 129.50 | 120.10 | -1.60 | -1.23% | 10.66M | 18/04 | ||
Barclays | 183.98 | 183.98 | 181.14 | +4.04 | +2.25% | 72.90M | 18/04 | ||
HSBC | 644.60 | 645.60 | 637.60 | +8.50 | +1.34% | 44.84M | 18/04 | ||
BAE Systems | 1,287.00 | 1,316.50 | 1,272.50 | -33.00 | -2.50% | 11.50M | 18/04 |
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review